Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Alexo Therapeutics, a clinical-stage immuno-oncology company developing therapies to block the CD47 myeloid checkpoint mechanism, today announced the change of the Company’s name to ALX Oncology. The new name and logo will differentiate ALX Oncology ...
read more
Alexza Pharmaceuticals has updated and amended its ADASUVE® (Staccato® loxapine) commercial partnerships with Grupo Ferrer Internacional, S.A. and Teva Pharmaceutical Industries Ltd.
read more
Algorics, a provider of biostatistics and programming solutions for the pharmaceutical and biotechnology industry, acquired Domain Clinical Data Sciences "DCDS", a clinical data services organization based in India.
read more
Alida Biosciences announced its first official service provider: the Genomic and RNA Profiling (GARP) Core at Baylor College of Medicine. This new service offering is powered by AlidaBio's EpiPlex™ Platform, the first and only solution that ...
read more
Wednesday, January 16, 2019
Align Clinical CRO and Veeva Systems announced its first technology standard is available for industry review and input.
read more
Alimentiv, formerly Robarts Clinical Trials, announced a major rebranding.
read more
Wednesday, April 14, 2021
A Commercial State-of-the-art Research Laboratory Delivering Histopathology And Precision Medicine Services For Global Clinical Trials.
read more
Wednesday, November 08, 2023
limentiv Inc., AcelaBio Inc., and PharmaNest Inc. announced their collaborative effort aimed at revolutionizing precision medicine and artificial intelligence (AI)-enabled digital pathology solutions for metabolic dysfunction-associated ...
read more
Alimentiv, Satisfai Health, and Virgo Surgical Video Solutions announced a strategic partnership to revolutionize central reading, data capture, decision support, and patient recruitment in the clinical trial domain for Inflammatory Bowel Disease (...
read more
Alimera Sciences Europe Limited has signed a distribution agreement with Nordic Prime ApS to serve as Alimera’s distribution partner in Denmark, Finland, Norway and Sweden for ILUVIEN® 190 micrograms intravitreal implant in applicator.
read more
Monday, September 21, 2020
Alimera Sciences Europe has signed a distribution agreement with Medis for the exclusive sales and distribution of ILUVIEN in the Czech Republic and Austria.
read more
Wednesday, February 05, 2020
X-Chem announced a drug discovery partnership with ALK, a Danish pharmaceutical company focused on the prevention and treatment of allergies.
read more
Alkermes has entered into a clinical research collaboration with Fred Hutchinson Cancer Research Center for ALKS 4230, Alkermes' immuno-oncology drug candidate.
read more
Tuesday, January 07, 2014
Alkermes plc (NASDAQ:ALKS) today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application 14/032,736, entitled “Prodrugs of fumarates and their use in treating various diseases....
read more
Alkermes plc (NASDAQ: ALKS) today announced that the United States Patent and Trademark Office (USPTO) has issued Notices of Allowance for four of Alkermes’ pipeline candidates for the treatment of central nervous system (CNS) disorders: aripiprazole...
read more